SOD1 and amyotrophic lateral sclerosis: Previous studies that have investigated P2X7R antagonism with JNJ-5567 and other P2X7R antagonists in the SOD1 mouse model of ALS show conflicting results in part due to differences in P2X7R antagonist dose regimens, treatment start time relative to disease progression and poor central nervous system bioavailability.